Earl Douglas - Aug 14, 2023 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Signature
/s/Lillian Smith, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
3
Date filed
8/17/2023, 02:50 PM
Next filing
Jan 31, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.